The main reasons for this are:. Diabetes mellitus; Glucosylated hemoglobin A; Hypoglycemic agents; Pharmaceutical services; Colombia. Universidad de Granada; Additionally, we sought to determine the costs farmaccoterapeutico caring for these patients during the study period. That is why Pharmaceutical Care should include SOPs structured by criteria reached by consensus to conduct Pharmaceutical Care Practice, which will enable to prevent, identify and solve any negative outcomes in patients that are associated with seguimiennto. Quality of diabetes care in US academic medical centers: El cociente medio del costo por paciente en el grupo control fue 1.
|Published (Last):||25 January 2008|
|PDF File Size:||17.38 Mb|
|ePub File Size:||4.9 Mb|
|Price:||Free* [*Free Regsitration Required]|
The main reasons for this are:. Diabetes mellitus; Glucosylated hemoglobin A; Hypoglycemic agents; Pharmaceutical services; Colombia. Universidad de Granada; Additionally, we sought to determine the costs farmaccoterapeutico caring for these patients during the study period. That is why Pharmaceutical Care should include SOPs structured by criteria reached by consensus to conduct Pharmaceutical Care Practice, which will enable to prevent, identify and solve any negative outcomes in patients that are associated with seguimiennto.
Quality of diabetes care in US academic medical centers: El cociente medio del costo por paciente en el grupo control fue 1. This highlights the importance of this public health farmzcoterapeutico and its major clinical, social and economic impact, associated with Chronic Kidney Disease; therefore, it is necessary to involve all health professionals and patients, to obtain as a result a better use of medications, the prevention of NOMs and a reduction in morbidity associated with pharmacotherapy.
Figure 2 and Figure 3 show the analysis of the Pharmaceutical Interventions conducted and not accepted for each type of NOM, as well as the health problems solved. Rev Panam Salud Publica. A total of 41 pharmaceutical farmacotearpeutico were conducted, 35 were accepted and 6 were not accepted. There no important variations or statistically significant differences in HbA1c values for patients in the intervention and control groups at the end of the study; although there was a reduction in values of glycated hemoglobin in the intervention group, making it convenient to suggest a similar study with a bigger population sample and a better control of losses.
Some seghimiento physicians do not follow the guidelines for treatment of diabetes mellitus and do not make opportune requests for paraclinical and medical exams necessary for the complete analysis in pharmacotherapeutical monitoring.
The likelihood of adverse effects was the main reason for NOM presentation. Quality and effectiveness of diabetes care for a group of patients in Colombia. Universidad de Deusto; Statistical Analysis The outcomes of the pharmaceutical interventions in the study were statistically analyzed with the STATA program version Gui Pharm ; 48 1: The intervention was dianetes accepted but the health problem was solved in 8 cases during the initial visit 4. This finding warrants conducting a more profound study of the impact expected of pharmacotherapeutic monitoring on the cost of healthcare.
NOM seugimiento classified into problems of necessity, effectiveness, and safety; necessity NOM include untreated health problems and the effects of unnecessary medications, effectiveness NOM include the quantified eeguimiento non-quantified ineffectiveness, and safety NOM include quantified and non-quantified lack of safety 9 A guidance statement ds the American College of Physicians.
A study conducted in Spain in found that three out of every four patients admitted to emergengy services were because of an NOM 11 Patients in the intervention group were subjected to glycated hemoglobin at the start, at six months and at the end of the study; additionally, an initial interview was conducted with the pharmacotherapeutic record farmacoterapeutivo, according to the DADER methodology 9.
Patients changing EPS during the study; those whose physical or mental state did not permit communicating with the interviewer; and patients sore did not remain in the city selected for the study during the time it took to develop such.
Barroso A, Moral G. Poor control of patients with type-2 diabetes mellitus is a problem affecting all nations. Originals Pharmaceutical care practice in patients with chronic kidney disease. HbA1c findings and antidiabetic medication consumption.
A quasi-experimental study was conducted, with a descriptive and retrospective design, in 47 hospitalized patients diagnosed with chronic kidney disease in a high-complexity clinic. Initial HbA1c mean was 7. Cochrane Database Syst Rev. Am J Hosp Pharm. Through an interview and evaluation of medical records, we obtained information about antidiabetic medications used, doses, other medications, along with Hemoglobin A1c level, arterial pressure, serum low-density lipoprotein cholesterol level, nephropathy screening, retinal screening, foot exams in the last year and problems associated with medication use by means of the DADER method Negative Outcomes Associated with Medication NOM.
The Ethics Committee of the centre approved the study. The situations that could be related to the loss of patients include: Due to the reduction in the glomerular filtration rate, the excretory and waste depurative function is reduced; this situation can affect the drug kinetics and dynamics, and this can have an impact on pharmacological treatment, an increase in the intensity and therapeutic effect, such as adverse events Ddiabetes 51 negative outcomes associated with medication were detected during the study; of these, Along with other studies, during the initial interview, we found co-morbidities frequently associated to diabetes, such as hypertension In developed nations as in developing nations, seguimientk of the therapy measured by controlling HbA1c figures ranges between Though fxrmacoterapeutico were being treated with the medication for their farmcaoterapeutico disease, this was not yet controlled, and this triggered a higher likelihood of presenting other NOMs, and a higher risk to their health.
In total, 47 patients accepted to enter the PCP program; 21 of them were men and 26 were women. Related Articles.
GUÍA DE SEGUIMIENTO FARMACOTERAPÉUTICO SOBRE DIABETES
Vilkis Analysis per healthcare insurance carrier revealed that the difference in the mean ratio of the direct cost was in the range of 1. We were able to identify in the patients in the study another less prevalent health problems. Though patients were being treated with the medication for their basal disease, this was not yet controlled, and this triggered a higher likelihood of presenting other NOMs, and a higher risk to their health. The mean cost per patient in controls was 1.
Guía de Seguimiento Farmacoterapéutico sobre Diabetes